These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32824587)

  • 41. TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.
    Dal Monte P; Landini MP; Sinclair J; Virelizier JL; Michelson S
    AIDS; 1997 Mar; 11(3):297-303. PubMed ID: 9147420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. S-adenosylhomocysteine hydrolase inhibitors interfere with the replication of human immunodeficiency virus type 1 through inhibition of the LTR transactivation.
    Daelemans D; Esté JA; Witvrouw M; Pannecouque C; Jonckheere H; Aquaro S; Perno CF; De Clercq E; Vandamme AM
    Mol Pharmacol; 1997 Dec; 52(6):1157-63. PubMed ID: 9396786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells.
    Forlani G; Turrini F; Ghezzi S; Tedeschi A; Poli G; Accolla RS; Tosi G
    J Transl Med; 2016 Apr; 14():94. PubMed ID: 27089879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation.
    Boven LA; Noorbakhsh F; Bouma G; van der Zee R; Vargas DL; Pardo C; McArthur JC; Nottet HS; Power C
    J Neurovirol; 2007 Apr; 13(2):173-84. PubMed ID: 17505986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.
    Romano G; Kasten M; De Falco G; Micheli P; Khalili K; Giordano A
    J Cell Biochem; 1999 Dec; 75(3):357-68. PubMed ID: 10536359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
    Endo-Munoz L; Warby T; Harrich D; McMillan NA
    Virol J; 2005 Feb; 2():17. PubMed ID: 15737233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of Tat-mediated transactivation and HIV replication with Tat mutant and repressor domain fusion proteins.
    Fraisier C; Abraham DA; van Oijen M; Cunliffe V; Irvine A; Craig R; Dzierzak EA
    Gene Ther; 1998 Jul; 5(7):946-54. PubMed ID: 9813666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The sequence and structure of the 3' arm of the first stem-loop of the human immunodeficiency virus type 2 trans-activation responsive region mediate Tat-2 transactivation.
    Browning C; Hilfinger JM; Rainier S; Lin V; Hedderwick S; Smith M; Markovitz DM
    J Virol; 1997 Oct; 71(10):8048-55. PubMed ID: 9311903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
    J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular factors regulate transactivation of human immunodeficiency virus type 1.
    Barry PA; Pratt-Lowe E; Unger RE; Luciw PA
    J Virol; 1991 Mar; 65(3):1392-9. PubMed ID: 1995949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
    Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
    mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery and characterization of an HIV-1 Tat antagonist.
    Hsu MC; Schutt AD; Holly M; Slice LW; Sherman MI; Richman DD; Potash MJ; Volsky DJ
    Biochem Soc Trans; 1992 May; 20(2):525-31. PubMed ID: 1397654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat.
    Taylor JP; Pomerantz RJ; Raj GV; Kashanchi F; Brady JN; Amini S; Khalili K
    J Virol; 1994 Jun; 68(6):3971-81. PubMed ID: 8189531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages.
    Moses AV; Ibanez C; Gaynor R; Ghazal P; Nelson JA
    J Virol; 1994 Jan; 68(1):298-307. PubMed ID: 8254741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antagonistic effect of interferon-gamma on tat-induced transactivation of HIV long terminal repeat.
    Emilie D; Maillot MC; Nicolas JF; Fior R; Galanaud P
    J Biol Chem; 1992 Oct; 267(29):20565-70. PubMed ID: 1400376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
    Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
    Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
    Zhang HS; Chen XY; Wu TC; Zhang FJ
    J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
    Zhang HS; Sang WW; Ruan Z; Wang YO
    Arch Biochem Biophys; 2011 Jan; 505(2):266-72. PubMed ID: 21029719
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphorylation of the RAP74 subunit of TFIIF correlates with Tat-activated transcription of the HIV-1 long terminal repeat.
    Zhou M; Kashanchi F; Jiang H; Ge H; Brady JN
    Virology; 2000 Mar; 268(2):452-60. PubMed ID: 10704353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Second exon of Tat of HIV-2 is required for optimal trans-activation of HIV-1 and HIV-2 LTRs.
    Tong-Starksen SE; Baur A; Lu XB; Peck E; Peterlin BM
    Virology; 1993 Aug; 195(2):826-30. PubMed ID: 8337847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.